We transcend borders, time zones, and especially the status quo to develop therapies that are more accessible to people around the world.

Learn More

Putting Patients First

Learn more about how we are working to discover and develop innovative medicines that are more accessible and affordable to patients around the world.

Science-Based, Passion-Driven

We are advancing an innovative, high-value product portfolio for patients globally.

Learn More

Passion with Purpose

We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.

Learn More

Our Commitment to Patients

We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”

Learn More

BeiGene News

January 23, 2024

BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors

Read more

December 22, 2023

FDA Approves Label Update for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic Leukemia (CLL)

Read more

December 21, 2023

BeiGene to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Read more

November 29, 2023

BeiGene to Host ASH Investor Meeting in Person and via Webcast on December 10, 2023

Read more

November 28, 2023

BeiGene to Present New Data Highlighting Hematology Portfolio and Pipeline Strengths at ASH 2023

Read more

November 21, 2023

BeiGene and Ensem Therapeutics Announce Partnership to Advance Differentiated CDK2 Inhibitor

Read more